Christoph Rischpler

Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury/remodeling

S. Nekolla, L. Umutlu, M. Totzeck, 2020, Journal of Nuclear Cardiology.

Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation

Konstantin Nikolaou, Thomas Beyer, Harald H Quick, 2019, Nuklearmedizin.

Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT

O. Pettersson, K. Herrmann, W. Fendler, 2023, European journal of nuclear medicine and molecular imaging.

Screening for Occult Transthyretin Amyloidosis in Patients with Severe Aortic Stenosis and Amyloid Red Flags

M. Papathanasiou, P. Luedike, A. Carpinteiro, 2024, Journal of clinical medicine.

Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives.

I. Mavroeidi, D. Kersting, S. Settelmeier, 2023, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Reply: Recent Evidence on Cardiac 99mTc-DPD Uptake After Therapy with Tafamidis May Reveal the Road to an Ultra-Early Diagnosis in Patients with ATTR Amyloidosis

M. Papathanasiou, P. Luedike, L. Kessler, 2024, The Journal of Nuclear Medicine.